Pharma & Biotech

Amphastar Pharmaceuticals finds itself at a puzzling crossroads as conflicting market signals create uncertainty for investors. While fundamental valuation metrics...

Viking Therapeutics shares delivered a contradictory performance on Tuesday, advancing 1.86 percent to reach $27.88 and outpacing the S&P 500's...

Bayer's stock faces a pivotal moment as Germany's DAX-listed pharmaceutical and agricultural giant tests the psychologically significant €30 price level....

Pharmaceutical giant Novo Nordisk is making calculated moves to sharpen its competitive edge, simultaneously advancing key pipeline assets while exiting...

Wednesday delivered an unexpected boost for Moderna as the biotechnology firm's stock surged more than 6%, marking a dramatic reversal...

Danaher Corporation is making significant strides in artificial intelligence integration across its life sciences portfolio, earning market approval for its...

BioNTech is charting a bold new course beyond its pandemic-era success, positioning artificial intelligence as the cornerstone of its next...

Baidu is making strategic moves on multiple fronts that could significantly enhance its standing in the global artificial intelligence competition....

Bristol-Myers Squibb has secured a significant regulatory achievement with the FDA granting Fast-Track status to its Alzheimer's disease candidate, BMS-986446....

The pharmaceutical industry is experiencing a significant breakthrough, with Eli Lilly emerging as a frontrunner in the current market upswing....